Compare LEDS & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEDS | COSM |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 12.9M |
| IPO Year | 2010 | 2009 |
| Metric | LEDS | COSM |
|---|---|---|
| Price | $1.92 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 67.8K | ★ 3.0M |
| Earning Date | 04-14-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.12 | 46.15 |
| EPS | ★ 0.02 | N/A |
| Revenue | $43,009,000.00 | ★ $65,271,815.00 |
| Revenue This Year | N/A | $54.08 |
| Revenue Next Year | N/A | $32.66 |
| P/E Ratio | $105.00 | ★ N/A |
| Revenue Growth | ★ 729.81 | 19.93 |
| 52 Week Low | $1.01 | $0.16 |
| 52 Week High | $3.62 | $1.32 |
| Indicator | LEDS | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 49.37 |
| Support Level | $1.58 | $0.17 |
| Resistance Level | $2.17 | $0.28 |
| Average True Range (ATR) | 0.20 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 10.64 | 54.38 |
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.